ReviewMolecular biology reports2026
Fish cell lines in aquaculture and biomedical research: A global perspective on development, repositories, and multidisciplinary applications.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fish cell lines are indispensable in vitro systems that support diverse research areas, including virology, immunology, ecotoxicology, and biomedical science. Fish represent the most species-rich vertebrate group with remarkable genomic diversity, providing valuable resources for specialised cellular models. Since the establishment of the first fish cell line (RTG-2) in 1962, the global repository has expanded to approximately 918 authenticated cell lines derived from over 211 species. This review presents a comprehensive overview of the historical progression, global repositories, and current standards for cell line authentication. It summarises methodological advances in primary culture initiation, the development of continuous cell lines, and improvements in cryopreservation techniques. This review also critically explains the wide-ranging applications of fish cell lines in aquatic virology, vaccine development, and standardised ecotoxicological assays. The translational potential in biomedical research is also highlighted, particularly in cancer biology, regenerative medicine, and drug discovery, largely driven by the use of genetically tractable model species such as zebrafish (Danio rerio) and medaka (Oryzias latipes). Key challenges are also discussed, including mycoplasma contamination, cross-species misidentification, limitations in cryopreservation protocols for marine-derived cells, and the need for robust, open-access digital biobanking systems. Future perspectives encompass emerging technologies such as 3D organoids, organ-on-a-chip platforms, CRISPR-based genome editing, and serum-free culture systems. Integration of these innovations with omics approaches and adverse outcome pathway frameworks is expected to enhance the utility of fish cell lines, advancing research in aquaculture, environmental monitoring, and food security, while aligning with the principles of the 3Rs and the United Nations Sustainable Development Goals.
Indexed as
Identifiers
42560549What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.